IN2014CN02982A - - Google Patents
Info
- Publication number
- IN2014CN02982A IN2014CN02982A IN2982CHN2014A IN2014CN02982A IN 2014CN02982 A IN2014CN02982 A IN 2014CN02982A IN 2982CHN2014 A IN2982CHN2014 A IN 2982CHN2014A IN 2014CN02982 A IN2014CN02982 A IN 2014CN02982A
- Authority
- IN
- India
- Prior art keywords
- glycosylated
- interferon
- activity
- glycosylated polypeptide
- carbohydrate structure
- Prior art date
Links
- 102000007079 Peptide Fragments Human genes 0.000 abstract 4
- 108010033276 Peptide Fragments Proteins 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 102000003996 Interferon-beta Human genes 0.000 abstract 2
- 108090000467 Interferon-beta Proteins 0.000 abstract 2
- 125000000837 carbohydrate group Chemical group 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 229960001388 interferon-beta Drugs 0.000 abstract 2
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011218793 | 2011-10-01 | ||
PCT/JP2012/075262 WO2013047846A1 (ja) | 2011-10-01 | 2012-09-28 | 糖鎖付加ポリペプチドおよび当該ポリペプチドを含む医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN02982A true IN2014CN02982A (enrdf_load_stackoverflow) | 2015-07-03 |
Family
ID=47995870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2982CHN2014 IN2014CN02982A (enrdf_load_stackoverflow) | 2011-10-01 | 2012-09-28 |
Country Status (16)
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2014CN02982A (enrdf_load_stackoverflow) | 2011-10-01 | 2015-07-03 | Glytech Inc | |
CN104334574B (zh) * | 2013-03-29 | 2020-01-14 | 株式会社糖锁工学研究所 | 附加唾液酸化糖链的多肽 |
CN114685645B (zh) * | 2020-12-30 | 2025-03-21 | 深圳翰宇药业股份有限公司 | 一种索玛鲁肽的合成方法 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0237019A3 (en) | 1986-03-14 | 1988-03-09 | Toray Industries, Inc. | Interferon conjugate and production thereof using recombinant gene |
CA2278178C (en) | 1997-01-16 | 2012-09-25 | Cytel Corporation | Practical in vitro sialylation of recombinant glycoproteins |
DE19717864C2 (de) | 1997-04-23 | 2001-05-17 | Fraunhofer Ges Forschung | Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung |
DK1075281T3 (da) * | 1998-04-28 | 2005-01-03 | Applied Research Systems | Polyol-IFN-beta-konjugater |
EP1121156B1 (en) | 1998-10-16 | 2006-02-22 | Biogen Idec MA Inc. | Polymer conjugates of interferon beta- 1a and their uses |
EA005005B1 (ru) * | 1998-10-16 | 2004-10-28 | Байоджен, Инк. | ГИБРИДНЫЙ ПОЛИПЕПТИД β1α-ИНТЕРФЕРОНА ЧЕЛОВЕКА, ЕГО МУТАНТНЫЕ ФОРМЫ И ПРОИЗВОДНЫЕ И СОДЕРЖАЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ |
US6514729B1 (en) | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
EP1240327B1 (en) * | 1999-12-08 | 2008-02-06 | Amgen Inc., | Interferon-like molecules and uses thereof |
US7795002B2 (en) * | 2000-06-28 | 2010-09-14 | Glycofi, Inc. | Production of galactosylated glycoproteins in lower eukaryotes |
JP2004518621A (ja) | 2000-09-08 | 2004-06-24 | グリフォン セラピューティクス,インコーポレーテッド | 「擬似」天然型化学的ライゲーション |
BR0207576A (pt) | 2001-02-27 | 2004-04-27 | Maxygen Aps | Variante glicosilada de um polipeptìdeo de interferon beta precursor (ifnb), processos de aumentar a glicosilação in vivo de uma molécula de ifnb precursora, de produzir uma molécula de ifnb glicosilada, para preparar uma variante conjugada e de tratar um mamìfero com esclerose múltiplam composição farmacêutica, molécula de ifnb variante, sequência de nucleotìdeo, vetor de expressão, célula hospedeira de glicosilação conjugado, e, uso de um conjugado |
PL362870A1 (en) | 2001-03-15 | 2004-11-02 | Merck Patent Gmbh | Modified interferon beta with reduced immunogenicity |
HK1080090B (zh) * | 2001-10-10 | 2012-12-14 | 诺和诺德公司 | 肽的重构和糖缀合的方法 |
US7226903B2 (en) * | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta |
WO2003054006A2 (en) | 2001-12-11 | 2003-07-03 | Aventis Pasteur | Mutated hiv tat |
US20060083715A1 (en) * | 2002-03-12 | 2006-04-20 | Steven Glazer | Interferon beta-like molecules for treatment of stroke |
US7943763B2 (en) | 2002-07-05 | 2011-05-17 | Otsuka Chemical Holdings Co., Ltd. | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
WO2004020468A2 (en) | 2002-08-28 | 2004-03-11 | Maxygen Aps | Interferon beta-like molecules for treatment of cancer |
NZ565990A (en) * | 2002-09-27 | 2009-10-30 | Biogen Idec Inc | Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
EP1581631A4 (en) | 2002-10-01 | 2007-09-05 | Xencor Inc | INTERFERON VARIANTS HAVING IMPROVED PROPERTIES |
US20060166929A1 (en) | 2002-12-26 | 2006-07-27 | Yasuhiro Kajihara | Sugar-chain asparagine derivatives and processes for the preparation thereof |
EP1666496B1 (en) | 2003-08-25 | 2014-03-12 | Toray Industries, Inc. | Interferon-beta composite |
EP1734988A4 (en) | 2004-03-01 | 2009-08-05 | Enzon Pharmaceuticals Inc | INTERFERON BETA-polymer |
RU2392963C2 (ru) * | 2004-08-09 | 2010-06-27 | Элиоз Байофарма, Инк. | Синтетические варианты гипергликозилированного протеазо-резистентного полипептида, пероральные композиции и способы применения таких вариантов |
EP1789074A4 (en) | 2004-08-09 | 2009-08-12 | Alios Biopharma Inc | PROTEASE-RESISTANT HYPERGLYCOSYL SYNTHETIC POLYPEPTIDE VARIANTS, ORAL FORMULATIONS AND METHODS OF USING THE SAME |
KR100781666B1 (ko) * | 2004-11-02 | 2007-12-03 | 신영기 | 인간 인터페론-베타 변이체 |
JP4944112B2 (ja) * | 2005-08-26 | 2012-05-30 | アレス トレーディング ソシエテ アノニム | グリコシル化されたインターフェロンベータの調製方法 |
US20080003202A1 (en) * | 2006-03-28 | 2008-01-03 | Thierry Guyon | Modified interferon-beta (IFN-beta) polypeptides |
US20080096819A1 (en) | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
TWI423821B (zh) | 2007-06-19 | 2014-01-21 | Glucose-containing glucagon-like peptide-1 peptide | |
RU2478105C2 (ru) | 2007-07-31 | 2013-03-27 | Глитек, Инк. | Способ получения пептида |
JP2009242372A (ja) | 2008-03-11 | 2009-10-22 | Yokohama City Univ | 均一な糖鎖構造を有するエリスロポエチン誘導体 |
KR101609005B1 (ko) | 2008-06-17 | 2016-04-04 | 가부시키가이샤 도우사 고가쿠 겐큐쇼 | 당쇄 부가 glp-1 펩티드 |
WO2010015722A1 (en) | 2008-08-08 | 2010-02-11 | Vib Vzw | Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof |
AU2009283678B2 (en) * | 2008-08-19 | 2014-01-16 | Glytech, Inc. | Glycoprotein production method and screening method |
WO2012051615A1 (en) | 2010-10-15 | 2012-04-19 | Transgenrx, Inc. | Novel vectors for production of glycosylated interferon |
KR101920947B1 (ko) | 2011-03-10 | 2018-11-21 | 가부시키가이샤 도우사 고가쿠 겐큐쇼 | 시알릴 당쇄를 갖는 당펩티드의 제조방법, 당해 제조방법에 사용하는 시알릴 당쇄 부가 아미노산 유도체 및 당해 당펩티드 |
US9487566B2 (en) | 2011-06-29 | 2016-11-08 | Kyowa Hakko Kirin Co., Ltd | Method for purifying protein |
IN2014CN02982A (enrdf_load_stackoverflow) | 2011-10-01 | 2015-07-03 | Glytech Inc |
-
2012
- 2012-09-28 IN IN2982CHN2014 patent/IN2014CN02982A/en unknown
- 2012-09-28 JP JP2013536471A patent/JP6153470B2/ja not_active Expired - Fee Related
- 2012-09-28 CN CN201280058952.8A patent/CN104080803B/zh active Active
- 2012-09-28 CA CA2850469A patent/CA2850469C/en active Active
- 2012-09-28 KR KR1020147010631A patent/KR101979045B1/ko not_active Expired - Fee Related
- 2012-09-28 PH PH1/2014/500694A patent/PH12014500694B1/en unknown
- 2012-09-28 SG SG11201401071YA patent/SG11201401071YA/en unknown
- 2012-09-28 DK DK12836998.0T patent/DK2762489T3/en active
- 2012-09-28 US US14/347,222 patent/US10358470B2/en active Active
- 2012-09-28 MY MYPI2014000925A patent/MY168902A/en unknown
- 2012-09-28 CN CN201811042210.1A patent/CN109134642A/zh active Pending
- 2012-09-28 AU AU2012317325A patent/AU2012317325B2/en not_active Ceased
- 2012-09-28 RU RU2014116550A patent/RU2636456C2/ru active
- 2012-09-28 EP EP12836998.0A patent/EP2762489B1/en active Active
- 2012-09-28 WO PCT/JP2012/075262 patent/WO2013047846A1/ja active Application Filing
- 2012-09-28 BR BR112014007766-5A patent/BR112014007766B1/pt not_active IP Right Cessation
- 2012-09-28 SG SG10201602076QA patent/SG10201602076QA/en unknown
- 2012-10-01 TW TW101136177A patent/TWI633115B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR112014007766B1 (pt) | 2022-05-10 |
JP6153470B2 (ja) | 2017-06-28 |
TWI633115B (zh) | 2018-08-21 |
EP2762489B1 (en) | 2018-03-28 |
WO2013047846A1 (ja) | 2013-04-04 |
RU2636456C2 (ru) | 2017-11-23 |
TW201321404A (zh) | 2013-06-01 |
MY168902A (en) | 2018-12-04 |
AU2012317325B2 (en) | 2016-10-06 |
PH12014500694B1 (en) | 2020-01-31 |
DK2762489T3 (en) | 2018-07-02 |
JPWO2013047846A1 (ja) | 2015-03-30 |
AU2012317325A1 (en) | 2014-04-17 |
BR112014007766A2 (pt) | 2017-04-04 |
CA2850469C (en) | 2020-07-07 |
SG11201401071YA (en) | 2014-08-28 |
CA2850469A1 (en) | 2013-04-04 |
US20140369964A1 (en) | 2014-12-18 |
PH12014500694A1 (en) | 2014-05-12 |
EP2762489A9 (en) | 2015-02-11 |
KR20140095051A (ko) | 2014-07-31 |
RU2014116550A (ru) | 2015-10-27 |
CN109134642A (zh) | 2019-01-04 |
KR101979045B1 (ko) | 2019-05-15 |
CN104080803B (zh) | 2020-08-04 |
CN104080803A (zh) | 2014-10-01 |
EP2762489A1 (en) | 2014-08-06 |
SG10201602076QA (en) | 2016-04-28 |
US10358470B2 (en) | 2019-07-23 |
EP2762489A4 (en) | 2015-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201805291TA (en) | Production of heterodimeric proteins | |
WO2012068317A3 (en) | Methods for producing recombinant proteins | |
MX367859B (es) | Metodos y materiales para la biosintesis de compuestos mogrosidos. | |
EP2680111A4 (en) | SUBSTRATE HAVING TRANSPARENT ELECTRODE, PRODUCTION METHOD THEREFOR, AND TOUCH SCREEN | |
EP4375371A3 (en) | Methods for the manufacture of proteolytically processed polypeptides | |
ZA201302115B (en) | Method for producing panels and panel produced according to the method | |
EP2865656A4 (en) | METHOD FOR MANUFACTURING GLASS PLATE HAVING CURVED PART AND GLASS PLATE HAVING CURVED PART | |
MX357965B (es) | Composicion farmaceutica para el tratamiento y/o prevencion de cancer de vesicula biliar. | |
MX358224B (es) | Composicion farmaceutica para el tratamiento y/o prevencion de cancer de higado. | |
MX340558B (es) | Anticuerpos biespecificos que comprenden fragmento fv estabilizado con disulfuro. | |
EP4477668A3 (en) | Heterodimeric antibody fc-containing proteins and methods for production thereof | |
MY160680A (en) | Process for producing molecules containing specialized glycan structures | |
PH12013500336A1 (en) | Peptide or peptide complex binding to alpha2 integrin and methods and uses involving the same | |
ZA201100656B (en) | Method for producing panels and panel produced according to the method | |
MX2014015768A (es) | Microorganismo recombinante para la produccion fermentativa de metionina. | |
IN2014MN01331A (enrdf_load_stackoverflow) | ||
WO2015021058A3 (en) | Engineered proteins with a protease cleavage site | |
MY181068A (en) | Recombinant microorganism for improved production of fine chemicals | |
MX2011012623A (es) | Construcciones de casb7439. | |
EP2784103A4 (en) | METHOD FOR PRODUCING A POLYMER COMPOSITE MATERIAL FROM A CARBON-CONTAINING MATERIAL AND POLYMER COMPOSITE MATERIAL FROM A CARBON-CONTAINING MATERIAL | |
MX2014004083A (es) | Metodo para aislar ingenol. | |
IN2014CN02982A (enrdf_load_stackoverflow) | ||
EP2632857A4 (en) | METHOD AND SYSTEM FOR PREPARING ANOLYT FRACTION | |
EP2876113A4 (en) | Method for producing a recombinant peptide and resultant peptide | |
UA117259C2 (uk) | Спосіб виготовлення гіпсової штукатурної плити |